| 36.33 Data as of 11:20am ET | -0.60 / -1.62%Today’s Change | 17.50 Today|||52-Week Range 42.30 | +88.63% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $373.5M |
Company Description
Furiex Pharmaceuticals is a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies to increase the value of the drug candidates by applying its novel approach to drug development. Furiex Pharmaceuticals was founded in October 2009 and is headquartered in Morrisville, NC.
Employees

Shareholders
| Other institutional | 33.63% |
| Individual stakeholders | 29.73% |
| Mutual fund holders | 15.03% |
Top Executives
| Fredric N. Eshelman, PhD | Founding Chairman |
| June Sherie Almenoff, MD, PhD | President, Director & Chief Medical Officer |
| Paul S. Covington, MD | Senior VP-Clinical Development & Operations |
| Marshall H. Woodworth, MBA, CFA | CFO, Treasurer & Assistant Secretary |
| Leonard Scott Dove, PhD | Executive Director-Clinical Operations |